Citadel Advisors - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$102,823,845
+69.2%
1,471,224
+73.9%
0.02%
+61.5%
Q2 2023$60,787,668
+74.3%
845,918
+49.6%
0.01%
+62.5%
Q1 2023$34,881,335
-70.6%
565,521
-63.2%
0.01%
-71.4%
Q4 2022$118,605,963
+35.1%
1,537,741
-21.8%
0.03%
+47.4%
Q3 2022$87,796,000
+54.4%
1,967,637
+32.5%
0.02%
+35.7%
Q2 2022$56,856,000
+17.7%
1,484,495
+27.2%
0.01%
+40.0%
Q1 2022$48,290,000
-15.9%
1,166,713
-23.3%
0.01%
-9.1%
Q4 2021$57,452,000
+42.9%
1,520,691
+24.7%
0.01%
+37.5%
Q3 2021$40,200,000
-36.4%
1,219,667
+30.1%
0.01%
-46.7%
Q2 2021$63,224,000
+58.6%
937,205
+33.1%
0.02%
+50.0%
Q1 2021$39,865,000
-51.6%
704,094
-30.3%
0.01%
-52.4%
Q4 2020$82,305,000
+106.9%
1,010,239
+81.0%
0.02%
+90.9%
Q3 2020$39,772,000
-34.6%
558,206
-24.5%
0.01%
-50.0%
Q2 2020$60,828,000
-20.3%
739,274
-43.0%
0.02%
-35.3%
Q1 2020$76,302,000
-29.3%
1,296,994
+24.3%
0.03%
-27.7%
Q4 2019$107,871,000
+1457.7%
1,043,643
+205.1%
0.05%
+1466.7%
Q3 2019$6,925,000
+67.1%
342,107
+112.6%
0.00%
+200.0%
Q2 2019$4,145,000
+118.2%
160,934
+20.6%
0.00%
Q1 2019$1,900,000
+3700.0%
133,476
+756.7%
0.00%
Q2 2018$50,000
-51.9%
15,581
+18.3%
0.00%
Q3 2016$104,00013,1710.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders